Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVA149 Heart Rate Safety in COPD
NCT00558285Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of indacaterol, glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
indacaterolglycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00558285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558285.